Understanding the risk of NMS in young patients

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment, among individuals ages 5-24 years.

Tracing Monkeypox virus: Leveraging ancient orangutan DNA to investigate the 1965 Rotterdam Zoo outbreak

Ancient DNA analysis of museum-preserved orangutan teeth reveals the cause of the 1965 zoo outbreak in the Netherlands as monkeypox virus (MPXV) infections, demonstrating the

March 13, 2024

Opinion | A Global Meeting of the Minds at Davos: What’s on the Horizon for Health?

David Nash is the Founding Dean Emeritus and Dr. Raymond C. and Doris N. Grandon Professor of Health Policy at the Jefferson College of Population

February 29, 2024

Opinion | Teen Therapy and Psychiatry Online: Hit or Miss?

Slater is a child and adolescent psychiatrist. I recently assessed a teenager hospitalized for an acetaminophen (Tylenol) overdose. Prior to the incident, she had sought

March 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.